Digital Technologies

Medtech M&A Is Thriving, Reports McKinsey

 

Only one year in the last decade involved more medtech acquisitions worth over $1bn than 2024, said McKinsey. A new report from the consulting firm found that despite an overall fall in activity for the life science sector, the economic and regulatory environment may support a strong rebound in dealmaking.

ACLA: Clinical Labs Hold ‘The Power Of Knowing’ For Patients

 

ACLA wants policymakers to see the vital role clinical labs play in delivering better health outcomes for patients and improving public health, especially in their potential for catching diseases early.

HIMSS 2025: Google Cloud Launches Visual Q&A For Multimodal Search Capabilities

 
• By 

Google Cloud launches new generative AI capabilities in Vertex AI for health care, allowing clinicians to gain access to multimodal data such as images and data to help with decision-making.

AvaSure, Oracle And NVIDIA Launch Virtual Care Assistant For Enhanced Clinical Workflow

 

AvaSure’s new in-hospital virtual care assistant utilizes Oracle's cloud platform and NVIDIA AI software packages to improve clinical workflow by grading patients’ responses to a question format.


FDA’s Cyber Device Regulations Demand Focus on Security, Webinar Says

 
• By 

A recent webinar highlighted the need for manufacturers to monitor, manage, and address software vulnerabilities under FDA cybersecurity policy. Important elements include a thorough software bill of materials, coordinated vulnerability disclosure, and maintaining system security.

HIMSS 2025: Microsoft Introduces First Unified Voice AI Assistant To Help Clinicians Streamline Documentation

 
• By 

Dragon Copilot combines and extends the capabilities of Microsoft Dragon Medical One voice dictation and DAX ambient listening to help clinicians streamline their entire workflow. It will be available in the US and Canada in May, followed by the UK, Germany, France and the Netherlands.

Prostate Cancer Research Urges UK To Implement Screening Program Without Delay

 

Implementing a reflex test alongside traditional prostate cancer screening is cost-effective for high-risk groups, claims Prostate Cancer Research. Oxford BioDynamics sheds light on UK market conditions influencing the adoption of its reflex test, EpiSwitch PSE.

Abbott First To Offer OTC Continuous Glucose Monitor On Amazon

 
• By 

Abbott is now offering its consumer CGM Lingo at Amazon for $49 for a single sensor. Its rival Dexcom also expects to introduce its consumer CGM Stelo on Amazon in Q1.


Seonix Bio’s Newly Launched Saliva-Based Genetic Test Aims To Shed Light On Glaucoma Risk Assessment

 
• By 

Seonix launched SightScore, the first clinical polygenic risk score test for glaucoma available in the US, and plans to introduce more genetic-based tests for eye conditions such as macular degeneration.

Philips Partners With Three Health Insurance Providers To Remotely Monitor High-Risk Pregnancies

 

Several counties in the US state of Georgia are maternity care “deserts.” Remote monitoring of high-risk pregnancies with maternal hypertension and diabetes could help improve the state’s high rate of maternal mortality, according to leading health service provider Philips.

Barcelona Health Hub: Where Digital Health Innovation Meets Historic Art Nouveau

 
• By 

In this first of a two-part series highlighting digital and healthtech innovation in Barcelona, Medtech Insight visits the Barcelona Health Hub, a nonprofit that seeks to advance digital health innovation by bringing together start-ups, investors, health care institutions and corporations.

‘Most, If Not All,’ CDRH Staffers Back On The Job

 

Most fired staffers in the FDA’s device center are now back at work, according to several who were unceremoniously let go over the President’s Day weekend purge.


New AI Tool Spots ‘Invisible’ Epilepsy Brain Lesions Missed By Radiologists

 

MELD Graph could help speed up the diagnosis and treatment of people with epilepsy by spotting "invisible" brain lesions often missed by radiologists. The new open-source AI tool developed by UK researchers could save the NHS up to $70,000 per patient, said researchers.

Philips And Mass General Brigham Collaborate To Unify Patient Data From EMRs And Bedside Devices

 

Royal Philips has taken a “significant step” in advancing live-data analytics in clinical practice in a new collaboration with US Mass General Brigham. The parties will leverage software platforms to unify EMR, lab and bedside medical devices data.

‘The World Doesn’t Need Another Digital Health App’ Says Health Tech Innovator Mike Trenell

 

The digital health market includes thousands of app-based solutions targeting single health conditions, but the cost, complexity and number of options “gives too many opportunities to health care systems to say no,” said Mike Trenell, Daiser CEO. The second generation of digital health might have the answers, he said.

Weekend FDA Purge Hits Device Center Hard, Many AI And Digital Health Staffers Gone

 

A flurry of firings as part of the Trump administration’s pledge to shrink the federal government hit the FDA over the weekend. While the exact number of staff let go is unclear, the agency’s device center took the brunt of it.


Boston Scientific Sets ‘New Clinical Innovation Standard’ For Pulsed Field Ablation

 

Boston Scientific has integrated cardiac mapping and pulsed field ablation into a single catheter with the newly EU-approved Farawave Nav Ablation Catheter. Faraview Software also receives CE marking, allowing for visualization of catheter placement when delivering therapy.

‘Profitability On The Horizon’ For UV-C Disinfection Solution Company Germitec

 

France-based Germitec aims to double its yearly revenue by expanding its UV-C disinfection technology for endocavitary ultrasound probes into the US market.

PathAI Enters South American Market Partnering With Integrated Healthcare Network Rede D’or

 

PathAI, a Boston-based AI-pathology startup backed by $355m, partners with Brazil’s largest integrated healthcare network to support diagnosis and treatment of cancer patients using its AISight image management system.

More Patients Free From Atrial Fibrillation With AI-Guided Pulmonary Vein Isolation Treatment

 

Volta Medical’s TAILORED-AF clinical trial demonstrates that AI can achieve "superior efficacy" in interventional cardiology. The study examined the use of AI-driven Volta AF-Xplorer in addition to pulmonary vein isolation in treating patient with persistent atrial fibrillation.